We are live on ! Find out more
MIM

MetLife Investment Management Portfolio holdings

AUM $19.6B
1-Year Est. Return 32.64%
This Fund
S&P 500
This Quarter Est. Return
+4.92%
1 Year Est. Return
+32.64%
3 Year Est. Return
+107.14%
5 Year Est. Return
+140.16%
10 Year Est. Return
–
AUM
$8.47B
AUM Growth
-$26.4M
Cap. Flow
-$317M
Cap. Flow %
-3.74%
Top 10 Hldgs %
16.75%
Holding
2,295
New
113
Increased
604
Reduced
562
Closed
131

Top Buys

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$33.8M
2
BNY
Bank of New York Mellon
BNY
+$16.4M
3
T icon
AT&T
T
+$9.63M
4
EFA icon
iShares MSCI EAFE ETF
EFA
+$7.05M
5
TWTR
Twitter, Inc.
TWTR
+$6.76M

Top Sells

Rank Stock Value
1
DD icon
DuPont de Nemours
DD
+$44.9M
2
BKNG icon
Booking.com
BKNG
+$30.5M
3
TWX
Time Warner Inc
TWX
+$22.2M
4
MON
Monsanto Co
MON
+$15.5M
5
AAPL icon
Apple
AAPL
+$14.5M

Sector Composition

Rank Sector Weight
1 Technology 17.18%
2 Financials 16.58%
3 Healthcare 12.69%
4 Industrials 10.83%
5 Consumer Discretionary 9.99%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LNTH icon
1776
Lantheus
LNTH
$6.58B
$266K ﹤0.01%
18,267
+5,201
+40% +$80K
MCFT icon
1777
MasterCraft Boat Holdings
MCFT
$585M
$266K ﹤0.01%
9,205
– –
DRNA
1778
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
$266K ﹤0.01%
+21,711
New +$273K
TCX icon
1779
Tucows
TCX
$145M
$265K ﹤0.01%
4,376
– –
OLBK
1780
DELISTED
Old Line Bancshares, Inc.
OLBK
$265K ﹤0.01%
7,597
+3,227
+74% +$110K
ANIP icon
1781
ANI Pharmaceuticals
ANIP
$1.71B
$264K ﹤0.01%
3,945
– –
ACRS icon
1782
Aclaris Therapeutics
ACRS
$867M
$263K ﹤0.01%
13,157
+3,244
+33% +$59.9K
FATE icon
1783
Fate Therapeutics
FATE
$325M
$262K ﹤0.01%
23,078
– –
ZUMZ icon
1784
Zumiez
ZUMZ
$321M
$262K ﹤0.01%
10,452
– –
FBK icon
1785
FB Financial Corp
FBK
$3.09B
$261K ﹤0.01%
6,411
– –
MTRX icon
1786
Matrix Service
MTRX
$333M
$260K ﹤0.01%
14,196
– –
NTRA icon
1787
Natera
NTRA
$45.6B
$260K ﹤0.01%
13,813
– –
NXRT
1788
NexPoint Residential Trust
NXRT
$623M
$260K ﹤0.01%
9,154
– –
BMRC icon
1789
Bank of Marin Bancorp
BMRC
$465M
$259K ﹤0.01%
6,398
– –
TAST
1790
DELISTED
Carrols Restaurant Group, Inc.
TAST
$259K ﹤0.01%
17,458
– –
PGNX
1791
DELISTED
Progenics Pharmaceuticals Inc
PGNX
$259K ﹤0.01%
32,263
– –
KE
1792
Kimball Electronics
KE
$613M
$258K ﹤0.01%
14,109
– –
UPLD icon
1793
Upland Software
UPLD
$14.6M
$258K ﹤0.01%
+750
New +$235K
CTRL
1794
DELISTED
Control4 Corporation
CTRL
$258K ﹤0.01%
10,604
– –
GFF icon
1795
Griffon
GFF
$4.73B
$257K ﹤0.01%
14,438
– –
GRC icon
1796
Gorman-Rupp
GRC
$2.18B
$256K ﹤0.01%
7,300
– –
LMAT icon
1797
LeMaitre Vascular
LMAT
$1.83B
$256K ﹤0.01%
7,651
– –
BFX
1798
DELISTED
BowFlex Inc.
BFX
$256K ﹤0.01%
16,328
– –
GOOD
1799
Gladstone Commercial Corp
GOOD
$627M
$255K ﹤0.01%
13,243
– –
HOFT icon
1800
Hooker Furnishings Corp
HOFT
$157M
$255K ﹤0.01%
5,444
– –
70 71
72
73 74

Similar funds

SPIA
Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
BG
Bahl & Gaynor Cincinnati, Ohio $19.8B AUM 19.53% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return
HHII
H&H International Investment Palo Alto, California $20B AUM 9.66% 1-Year Est. Return
LF
Lansforsakringar Fondforvaltning Stockholm, Sweden $19.1B AUM 26.9% 1-Year Est. Return
EIM
Elliott Investment Management West Palm Beach, Florida $20.1B AUM 60.76% 1-Year Est. Return

MetLife Investment Management's Q2 2018 Portfolio in Review

As of Q2 2018, MetLife Investment Management held 2,295 positions worth $8.47B, down 0.31% from $8.49B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

MetLife Investment Management withdrew a net $317M in Q2 2018, closing 131 positions and reducing 562 holdings. Its most notable exit was DuPont de Nemours, an estimated $44.9M position sold in full.

By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 17% a quarter earlier, followed by Financials and Healthcare.

Against the trend, MetLife Investment Management opened a new position in Bank of New York Mellon worth $16M.

  • MetLife Investment Management's largest Q2 2018 buy was Bank of New York Mellon: 297,519 shares worth $16M.
  • MetLife Investment Management added most to State Street SPDR S&P 500 ETF Trust in Q2 2018, an estimated $33.8M increase.
  • MetLife Investment Management's biggest Q2 2018 reduction was Apple, cutting an estimated $14.5M.
  • MetLife Investment Management fully exited DuPont de Nemours in Q2 2018, selling an estimated $44.9M.
  • MetLife Investment Management's ten largest holdings make up 17% of its $8.47B portfolio in Q2 2018.
  • MetLife Investment Management opened 113 new positions and closed 131 in Q2 2018.
  • MetLife Investment Management's portfolio value fell 0.31% quarter-over-quarter to $8.47B.

Based on MetLife Investment Management's 13F filing for Q2 2018, filed 15 Aug 2018.